Patents by Inventor Jokin Del Amo Iribarren

Jokin Del Amo Iribarren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas
    Patent number: 9702879
    Abstract: The present invention relates to in vitro methods and products for detecting the presence of an invasive carcinoma in an individual, for determining and/or predicting the stage and/or invasiveness of said carcinoma in an individual, or for monitoring the effect of the therapy administered to an individual who has said carcinoma based on col11a1 gene and proCOL11A1 protein expression. The invention also relates to the search for, identification, development and evaluation of the efficacy of compounds for therapy for said carcinoma, for the purpose of developing new medicinal products. The invention also relates to agents inhibiting proCOL11A1 protein expression and/or activity, and/or the effects of this expression.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: July 11, 2017
    Assignee: Oncomatryx Biopharma, S.L.
    Inventors: Luis Barneo Serra, Carmen Garcia Pravia, Juan Ramon De Los Toyos Gonzalez, Marcos Garcia Ocana, Jose Fernando Vazquez Villa, Nelson Fuentes Martinez, Jokin Del Amo Iribarren, Laureano Simon Buela
  • METHODS AND PRODUCTS FOR IN VITRO DIAGNOSIS, IN VITRO PROGNOSIS AND THE DEVELOPMENT OF DRUGS AGAINST INVASIVE CARCINOMAS
    Publication number: 20150362496
    Abstract: The present invention relates to in vitro methods and products for detecting the presence of an invasive carcinoma in an individual, for determining and/or predicting the stage and/or invasiveness of said carcinoma in an individual, or for monitoring the effect of the therapy administered to an individual who has said carcinoma based on col11a1 gene and proCOL11A1 protein expression. The invention also relates to the search for, identification, development and evaluation of the efficacy of compounds for therapy for said carcinoma, for the purpose of developing new medicinal products. The invention also relates to agents inhibiting proCOL11A1 protein expression and/or activity, and/or the effects of this expression.
    Type: Application
    Filed: August 8, 2012
    Publication date: December 17, 2015
    Inventors: Luis Barneo Serra, Carmen Garcia Pravia, Juan Ramon De Los Toyos Gonzalez, Marcos Garcia Ocana, Jose Fernando Vazquez Villa, Nelson Fuentes Martinez, Jokin Del Amo Iribarren, Laureano Simon Buela
  • IN VITRO METHODS FOR DETECTING RENAL CANCER
    Publication number: 20110098191
    Abstract: The present invention refers to an in vitro method for detecting the presence of renal cancer in an individual, for determining the stage, malignancy or severity of said carcinoma in the individual or for monitoring the effect of the therapy administered to an individual having said cancer; to the search, identification, development and assessment of the efficacy of compounds for therapy for said cancer in an attempt to develop new drugs; as well as to agents inducing Plexin-131 protein expression and/or activity, or to agents inhibiting the effects of Plexin-B1 protein expression and/or activity repression.
    Type: Application
    Filed: September 7, 2010
    Publication date: April 28, 2011
    Applicant: PROGENIKA BIOPHARMA, S.A.
    Inventors: Jose Javier Gomez Roman, Maria Pilar Saenz Jimenez, Jorge Ochoa Garay, Jokin Del Amo Iribarren, Cristina Sanz Ibayondo, Corina Junquera Sanchez-Vallejo, Laureano Simon Buela, Antonio Martinez Martinez, Jose Fernando Val Bernal, Jorge Cuevas Gonzalez
  • IN VITRO METHODS FOR DETECTING RENAL CANCER
    Publication number: 20080274968
    Abstract: The present invention refers to an in vitro method for detecting the presence of renal cancer in an individual, for determining the stage, malignancy or severity of said carcinoma in the individual or for monitoring the effect of the therapy administered to an individual having said cancer; to the search, identification, development and assessment of the efficacy of compounds for therapy for said cancer in an attempt to develop new drugs; as well as to agents inducing Plexin-131 protein expression and/or activity, or to agents inhibiting the effects of Plexin-B1 protein expression and/or activity repression.
    Type: Application
    Filed: April 16, 2008
    Publication date: November 6, 2008
    Applicant: PROGENIKA BIOPHARMA, S.A.
    Inventors: Jose Javier Gomez Roman, Maria Pilar Saenz Jimenez, Jorge Ochoa Garay, Jokin Del Amo Iribarren, Cristina Sanz Ibayondo, Corina Junquera Sanchez-Vallejo, Laureano Simon Buela, Antonio Martinez Martinez, Jose Fernando Val Bernal, Jorge Cuevas Gonzalez
  • In Vitro Methods for Detecting Renal Cancer
    Publication number: 20080015143
    Abstract: The present invention refers to an in vitro method for detecting the presence of renal cancer in an individual, for determining the stage, malignancy or severity of said carcinoma in the individual or for monitoring the effect of the therapy administered to an individual having said cancer; to the search, identification, development and assessment of the efficacy of compounds for therapy for said cancer in an attempt to develop new drugs; as well as to agents inducing Plexin-131 protein expression and/or activity, or to agents inhibiting the effects of Plexin-B1 protein expression and/or activity repression.
    Type: Application
    Filed: June 30, 2004
    Publication date: January 17, 2008
    Inventors: Jose Javier Gomez Roman, Maria Pilar Saenz Jimenez, Jorge Ochoa Garay, Jokin Del Amo Iribarren, Cristina Sanz Ibayondo, Corina Junquera Sanchez-Vallejo, Laureano Simon Buela, Antonio Martinez Martinez, Jose Fernando Val Bernal, Jorge Cuevas-Gonzalez